Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ANVS

Annovis Bio (ANVS)

Annovis Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:ANVS
DateTimeSourceHeadlineSymbolCompany
04/01/20247:00AMGlobeNewswire Inc.Annovis Announces Publication That Supports Understanding of Buntanetap’s Mechanism of Action in HumansAMEX:ANVSAnnovis Bio Inc
03/20/20246:30AMGlobeNewswire Inc.Annovis Bio Provides Data Announcement Update for the Phase II/III Study of Buntanetap in Alzheimer’s DiseaseAMEX:ANVSAnnovis Bio Inc
02/27/20247:00AMGlobeNewswire Inc.Annovis Bio Announces Participation in Forum Discussion at AD/PD™ 2024AMEX:ANVSAnnovis Bio Inc
02/14/20246:30AMGlobeNewswire Inc.Annovis Bio Announces Last Patient Last Visit in the Phase II/III Study of Buntanetap in Alzheimer’s DiseaseAMEX:ANVSAnnovis Bio Inc
01/30/20247:00AMGlobeNewswire Inc.Annovis Bio Announces the Filing of New Patent Application for Treatment of Mental Illnesses Expanding the Company’s PortfolioAMEX:ANVSAnnovis Bio Inc
01/24/20247:00AMGlobeNewswire Inc.Annovis Bio Refines Timeline for Parkinson’s Phase III Study Data AnnouncementAMEX:ANVSAnnovis Bio Inc
12/11/202312:00PMGlobeNewswire Inc.Annovis Bio to Participate in the 139th Yale CEO SummitAMEX:ANVSAnnovis Bio Inc
12/05/20236:30AMGlobeNewswire Inc.Annovis Bio Announces Last Patient Last Visit in the Phase III Study of Buntanetap in Parkinson’s DiseaseAMEX:ANVSAnnovis Bio Inc
12/01/20236:30AMGlobeNewswire Inc.Annovis Bio Appoints Andrew Walsh as Vice President FinanceAMEX:ANVSAnnovis Bio Inc
11/27/20236:30AMGlobeNewswire Inc.Annovis Bio Announces Full Enrollment of Its Phase II/III Alzheimer’s Disease Trial, Exceeding Original ProjectionsAMEX:ANVSAnnovis Bio Inc
11/08/20234:00PMGlobeNewswire Inc.Annovis Bio Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateAMEX:ANVSAnnovis Bio Inc
10/12/20237:02AMGlobeNewswire Inc.Annovis Bio Announces Positive Interim Independent Analysis for Statistical Power in Its Alzheimer’s StudyAMEX:ANVSAnnovis Bio Inc
06/16/20233:19PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
05/30/20234:20PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
05/10/20233:35PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:ANVSAnnovis Bio Inc
04/28/20237:01AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:ANVSAnnovis Bio Inc
04/26/20233:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
04/25/20235:01AMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:ANVSAnnovis Bio Inc
04/03/20234:29PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
04/03/20236:53AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
03/31/20238:19AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
02/08/20234:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
01/20/20234:44PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
01/20/20234:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
01/20/20234:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
01/20/20234:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
01/20/20234:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
01/06/20233:06PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
11/08/20223:45PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:ANVSAnnovis Bio Inc
09/12/20224:10PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
 Showing the most relevant articles for your search:AMEX:ANVS